Health Misinformation and Disinformation: How to Recognize and Avoid It
Statins May Reduce Liver Cancer Risk and Improve Liver Health
Brazilian Study Explores Kefir’s Potential in Combating Alzheimer’s Disease
The Impact of Diet on Inflammatory Bowel Disease (IBD)
Night Owls May Face Higher Risk of Depression Compared to Early Risers
The Impact of NSAID Use on Dementia Risk: Duration Matters
Swapping Butter for Plant-Based Oils Linked to Lower Risk of Premature Death
Rise in Measles Cases Sparks Interest in Vitamin A Supplements: What Experts Say
Better Heart Health May Lower Risk of Neurodegenerative Diseases
November 28, 2024
Doromongy Faces Backlash for Allegedly Selling Ozempic Injections
Mongy Semakaleng Mathobela, founder of Doro Mongy Empire, is under fire for reportedly selling Ozempic injections.
Known for her diverse product range, including skincare and gym sets, Mathobela allegedly added the diabetes drug—commonly misused for weight loss—to her offerings. The South African Health Products Regulatory Authority (SAHPRA) has warned against unauthorized Ozempic sales, citing potential health risks and its limited availability for diabetic patients.
Controversial blogger Musa Khawula claimed the injections were priced at R23,000, sparking legal and ethical concerns among social media users.
Copyright © 2025 Dotcom Africa. All Rights Reserved. Terms of Service | Contact | Advertise with us | About Us